Xie Juhua is a Chinese businesswoman, a director and the largest individual shareholder at Kingfriend (SHA: 603933), a major pharmaceuticals supplier.

Kingfriend's main products include cardiovascular and anti-tumor drugs. The company is controlled by the family, with Xie's son, Tang Yongqun, serving as the chairman of Kingfriend.

• Core Company: Kingfriend (Pharmaceuticals supplier).
• Key Role: Director and largest individual shareholder.
• Products: Supplies cardiovascular and anti-tumor drugs.

Xie Juhua's career is defined by her ownership and governance role in the pharmaceutical industry. Her structural contribution is tied to the long-term stability and strategic oversight of Kingfriend, a company that manufactures essential drugs.

She is the largest individual shareholder of the company. Her son, Tang Yongqun, leads the executive management as chairman, ensuring continued family control and direction.

• Family Governance: Son Tang Yongqun serves as chairman.